Authors


Stephanie Woo, OD, FAAO, FSLS

Latest:

CRU 2025: Sipping fine wine and sharpening minds

Discover a unique blend of cutting-edge eye care education and world-class wine tasting at the CRU Eye Symposium in Napa Valley, where learning meets luxury in an intimate setting.



Isabella Ortiz

Latest:

New topical therapies for dry eye disease

Nasal spray may fill the gaps left by artificial tears.


Benjamin Gaddie, OD, FAAO

Latest:

What optometrists gained from attending SECO 2025

Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.


Brian Shafer, MD

Latest:

Fortified antibiotic advance improves corneal infection treatment paradigm

Private practice eye care providers’ ability to immediately administer antibiotic eye drops or have them overnighted to the patient is a giant step forward for practice and patient.


Jessilin Quint, OD, MBA, MS, FAAO

Latest:

New practice? No problem!: Seasoned practice owners give practice management advise

Practice owners testify to the importance of trying new things, not being afraid to fail, and utilizing community as a resource when starting up a new practice.


Mark Bullimore, MCOptom, PhD

Latest:

Brainstorming eye care research expansion with unlimited resources

From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.


Dennis P. Pardo, OD, MPH, FAAO, LCSW

Latest:

AAOpt 2023: Plenary: Mental health and optometry

Bringing awareness, understanding, and embracing mental health care gives clinicians the space to best support and empower their patients, as well as themselves.


Ryan Beck, OD

Latest:

A beginner’s guide to dry eye treatment integration

Adding a service to your practice can be scaled to your liking.


Abby Gillogly Harsch, OD, FAAO, FSLS

Latest:

GSLS 2025: Scleral lens fitting in a keratoconus patient with a complex history

Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.


Emily Aristizabal

Latest:

Patient experiences sudden decrease in vision

Imaging shows optic disc swelling and retinal nerve fiber layer thickening


Joanna Reiman, OD

Latest:

How contact lens prescription brings sustainability into focus

Partnership helps keep oceans clean by collecting plastic waste, reducing pollution.


Catherine L. Heyman, OD, FAAO, FCOVD

Latest:

Tips on creating a space, treating patients with special needs

Catherine L. Heyman, OD, FAAO, FCOVD, shares highlights from her AOA 2022 presentation, "Evaluation and Management of Patients with Special Needs."


Thomas V. Johnson, MD, PhD

Latest:

EyeCon 2023: Pearls for monitoring intraocular pressure at home and in the office

Real-time insights into fluctuations enhance glaucoma care and understanding of vision risk.


Adler
Richard A. Adler, MD, FACS

Latest:

Viewing ptosis through a biopsychosocial lens

Low-lying lids affect much more than patients' visual field, with implications for visual quality and their self-esteem.


Bi Yang

Latest:

The latest and greatest in myopia control

Control measures in China are ahead of US measures.


Brenda Montecalvo, OD

Latest:

Addressing symptom relief of optic neuritis in multiple sclerosis

Contoured prism lenses may resolve symptoms such as neck, shoulder, and head pain.


Stephen Cohen, OD

Latest:

Tackling the problem of contact lens dropout from presbyopia

With advanced, easy-to-fit multifocal lens technologies, patients don’t need to compromise



Megan Cavet, PhD

Latest:

ARVO 2024: Understanding the pharmacokinetics of latanoprost and prednisolone acetate with perfluorohexyloctane

The rabbit model found that the levels of the active metabolites were very comparable, whether or not eyes had received a prior installation of perfluorohexyloctane.


Jim Sluck

Latest:

Sight Sciences' fair access campaign aims for insured access to heat and expression therapy for meibomian gland dysfunction

Jim Sluck, VP of Marketing for Sight Sciences' TearCare, shares the impetus behind the company's fair access campaign.


Nishan Pressley, OD

Latest:

Vision Expo East 2025: An exclusive Q&A on finding the right fit for dual, contact lens wear – Part 2

Charissa Lee, OD, MBA, FAAO; Ryan Corte, OD; Roxanne Achong-Coan OD, FAAO, FIAOMC, FSLS, Dip CCLRT; and Nishan Pressley, OD; give their insights on distinguishing the best candidates for contact lens wear.


Emily Rich

Latest:

Impact of vision impairment on children’s mental health

Studies conducted with Orbis International conclude positive mental health and academic improvements of children provided appropriate eye care and glasses, filling important research gaps and providing essential guidance for future interventions and research.


Rhea Magee, OD

Latest:

NOA 2023: Insights and lessons from a pediatric patient case

At NOA 2023 in Fort Lauderdale, Florida, Rhea Magee, OD, presented a pediatric patient case as part of the Resident Grand Rounds.


Maria K. Walker, OD, PhD

Latest:

Basic and beyond: technology for every level of scleral lens management

How to fit lenses with simple devices and when to expand your armature.


John Berdahl, MD

Latest:

Comanaging with the goal of better patient care

Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.


Carla Calizaire

Latest:

AAOpt 2023: Raising awareness for vision health

Optometry Times sat down with Carla Calizaire, Global Leader of Diversity Inclusion for Johnson and Johnson Med Tech to go in depth about the Vision Made Possible and Sight for Kids campaign.


Adam S. Wenick, MD, PhD

Latest:

EyeCon 2024: Myopia interventions across the lifespan

Adam S. Wenick, MD, PhD, discussed myopia interventions across the lifespan at EyeCon 2024, covering treatments, complications, and prevention strategies.


Sydney M Crago, Editor, Modern Retina

Latest:

CDR-Life completes fifth milestone and is recruiting patients for Phase 2 study of BI 771716

This follows successful Phase 1 results, which demonstrated a favorable safety profile for BI 771716 across both single and multiple intravitreal doses.


© 2025 MJH Life Sciences

All rights reserved.